top of page

What's new in HealthTech & MedTech [January]

Updated: Jan 17, 2023

In today's article, Indo Search Director Josh Craven looks at what is new in MedTech and HealthTech this January.


Bernard Ross, CEO of Sky Medical Technology, highlights what

he expects from the world of MedTech and healthcare going into

2023.




As MedTech further matures in 2023 and beyond, there will be challenges and opportunities for the industry.

 

European Commission formalizes plan to extend MDR transition out to 2027, 2028.





Having accepted that notified body capacity “remains insufficient,” the Commission shared a formal proposal to give manufacturers until 2027 or 2028, depending on risk classification, to get their devices designated under MDR.

 

Cambridge Design Partnership and CPI launch roadmap for UK IVD industry.






The Roadmap, researched and written by Cambridge Design Partnership, in partnership with CPI, the Association of British HealthTech Industries (ABHI), and funded by Innovate UK, defines the key technologies and strategies that can place the UK at the forefront of this industry.

 

Medical imaging company Perspectum raises £30m.






Precision health technology company Perspectum has closed $36m (£30.4m) in its first round of Series C funding, led by Oppenheimer Holdings. Oxford headquartered Perspectum provides body imagery software that connects to MRI machines and uses artificial intelligence (AI) to diagnose and monitor patients with chronic diseases.

 

Innovate UK grants £1m to help digitise medicine.




Developed by UK-based start-up CONNECT Care, the technology takes data currently siloed in medical records. It puts it into contextualised, personalised information that helps patients and health professionals make links between medicines and their impact on an individual’s more comprehensive health.

 

UK Losing HealthTech SMEs to the US




HealthTech SMEs from the UK are turning to the US as they struggle to cope with confusing regulatory measures and a lack of communication support. A new insights report from CPI has revealed that 24% of UK-based HealthTech SMEs aim to launch their innovations in the US rather than the UK.

 

Huma to provide best-in-class digital clinical trial solutions through the landmark acquisition of Alcedis.




Headquartered in Germany, Alcedis has more than 25 years of clinical trial

experience. Huma's award-winning technologies have been deployed since 2011.

Between them, Huma and Alcedis have managed nearly a thousand studies

across a wide range of therapeutic areas, including rare diseases, oncology,

immunology, cardiovascular, respiratory, neurodegenerative, musculoskeletal,

dermatology and metabolic diseases in over 60 countries involving more than

650,000 participants.

 

Rising number of foreign objects found in patients after surgery in England.




In what NHS calls ‘never events’, items including swabs, blades and drill bits left in patients 291 times in England in 2021-22.

 

Olympus agrees to $80M takeover of artificial intelligence endoscopy startup Odin Vision.




Odin is a London-based developer of Caddie and Cadu, cloud-based AI systems designed to help detect and characterize cancerous and precancerous tissues during colonoscopies and gastroscopies.

 

Vinehealth and Pocdoc including on the most disruptive and innovative list.




Congratulations to Vinehealth and Pocdoc, who are celebrating being included

by Startups.co.uk in the UK’s longest-running index of the 100 most disruptive

and innovative small businesses



38 views0 comments

Recent Posts

See All
bottom of page